{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:48:35Z","timestamp":1790912915708,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,26]]},"DOI":"10.7759\/cureus.65403","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T07:37:48Z","timestamp":1721979468000},"source":"Crossref","is-referenced-by-count":4,"title":["An Updated Review of Resistin and Colorectal Cancer"],"prefix":"10.7759","author":[{"given":"Aliki Vaia","family":"Rompou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyfalia","family":"Bletsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Tsakogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Theocharis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panteleimon","family":"Vassiliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Danias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan CM","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, et al.. The hormone resistin links obesity to diabetes. Nature. 2001, 409:307-12. 10.1038\/35053000","journal-title":"Nature"},{"key":"ref2","article-title":"Relationship of serum resistin with insulin resistance and obesity","volume":"27","author":"Zaidi SI","year":"2015","unstructured":"Zaidi SI, Shirwany TA. Relationship of serum resistin with insulin resistance and obesity. J Ayub Med Coll Abbottabad. 2015, 27:552-5.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.01.019","article-title":"The role of resistin in colorectal cancer","volume":"413","author":"Danese E","year":"2012","unstructured":"Danese E, Montagnana M, Minicozzi AM, et al.. The role of resistin in colorectal cancer. Clin Chim Acta. 2012, 413:760-4. 10.1016\/j.cca.2012.01.019","journal-title":"Clin Chim Acta"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7367485","article-title":"Circulating resistin levels and risk of colorectal cancer: a meta-analysis","volume":"2016","author":"Yang G","year":"2016","unstructured":"Yang G, Fan W, Luo B, et al.. Circulating resistin levels and risk of colorectal cancer: a meta-analysis. Biomed Res Int. 2016, 2016:10.1155\/2016\/7367485","journal-title":"Biomed Res Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.04.016","article-title":"Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms","volume":"120","author":"Avtanski D","year":"2019","unstructured":"Avtanski D, Garcia A, Caraballo B, et al.. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms. Cytokine. 2019, 120:155-64. 10.1016\/j.cyto.2019.04.016","journal-title":"Cytokine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13704","article-title":"Resistin facilitates metastasis of lung adenocarcinoma through the TLR4\/Src\/EGFR\/PI3K\/NF-\u03baB pathway","volume":"109","author":"Gong WJ","year":"2018","unstructured":"Gong WJ, Liu JY, Yin JY, et al.. Resistin facilitates metastasis of lung adenocarcinoma through the TLR4\/Src\/EGFR\/PI3K\/NF-\u03baB pathway. Cancer Sci. 2018, 109:2391-400. 10.1111\/cas.13704","journal-title":"Cancer Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2011_02_124","article-title":"Relationship of resistin levels with endometrial cancer risk","volume":"58","author":"Hlavna M","year":"2011","unstructured":"Hlavna M, Kohut L, Lipkova J, Bienertova-Vasku J, Dostalova Z, Chovanec J, Vasku A. Relationship of resistin levels with endometrial cancer risk. Neoplasma. 2011, 58:124-8. 10.4149\/neo_2011_02_124","journal-title":"Neoplasma"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/619649","article-title":"Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients","volume":"2014","author":"Diakowska D","year":"2014","unstructured":"Diakowska D, Markocka-M\u0105czka K, Szelachowski P, Grabowski K. Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients. Dis Markers. 2014, 2014:10.1155\/2014\/619649","journal-title":"Dis Markers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-21-59","article-title":"Resistin-induced stromal cell-derived factor-1 expression through toll-like receptor 4 and activation of p38 MAPK\/ NF\u03baB signaling pathway in gastric cancer cells","volume":"21","author":"Hsieh YY","year":"2014","unstructured":"Hsieh YY, Shen CH, Huang WS, et al.. Resistin-induced stromal cell-derived factor-1 expression through toll-like receptor 4 and activation of p38 MAPK\/ NF\u03baB signaling pathway in gastric cancer cells. J Biomed Sci. 2014, 21:10.1186\/1423-0127-21-59","journal-title":"J Biomed Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09813.x","article-title":"Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation","volume":"108","author":"Kim HJ","year":"2011","unstructured":"Kim HJ, Lee YS, Won EH, et al.. Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU Int. 2011, 108:E77-83. 10.1111\/j.1464-410X.2010.09813.x","journal-title":"BJU Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.05.005","article-title":"Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer","volume":"35","author":"Kallio J","year":"2017","unstructured":"Kallio J, H\u00e4m\u00e4l\u00e4inen M, Luukkaala T, Moilanen E, Tammela TL, Kellokumpu-Lehtinen PL. Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer. Urol Oncol. 2017, 35:544.e25-31. 10.1016\/j.urolonc.2017.05.005","journal-title":"Urol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27631","article-title":"Resistin effects on pancreatic cancer progression and chemoresistance are mediated through its receptors CAP1 and TLR4","volume":"234","author":"Zhang M","year":"2019","unstructured":"Zhang M, Yan L, Wang GJ, Jin R. Resistin effects on pancreatic cancer progression and chemoresistance are mediated through its receptors CAP1 and TLR4. J Cell Physiol. 2019, 234:9457-66. 10.1002\/jcp.27631","journal-title":"J Cell Physiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9040079","article-title":"Exploring the inflammatory pathogenesis of colorectal cancer","volume":"9","author":"Khalyfa AA","year":"2021","unstructured":"Khalyfa AA, Punatar S, Aslam R, Yarbrough A. Exploring the inflammatory pathogenesis of colorectal cancer. Diseases. 2021, 9:10.3390\/diseases9040079","journal-title":"Diseases"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1615\/critrevoncog.v12.i3-4.50","article-title":"Colorectal cancer: a multipathway disease","volume":"12","author":"Jass JR","year":"2006","unstructured":"Jass JR. Colorectal cancer: a multipathway disease. Crit Rev Oncog. 2006, 12:273-87. 10.1615\/critrevoncog.v12.i3-4.50","journal-title":"Crit Rev Oncog"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000341882","article-title":"MicroRNAs and inflammation in the pathogenesis and progression of colon cancer","volume":"30","author":"Okayama H","year":"2012","unstructured":"Okayama H, Schetter AJ, Harris CC. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis. 2012, 30:9-15. 10.1159\/000341882","journal-title":"Dig Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies","volume":"126","author":"Rinaldi S","year":"2010","unstructured":"Rinaldi S, Cleveland R, Norat T, et al.. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer. 2010, 126:1702-15. 10.1002\/ijc.24927","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30729","article-title":"Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: a population-based observational study","volume":"141","author":"Tsujimoto T","year":"2017","unstructured":"Tsujimoto T, Kajio H, Sugiyama T. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: a population-based observational study. Int J Cancer. 2017, 141:102-11. 10.1002\/ijc.30729","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.012","article-title":"Association between sex hormones and colorectal cancer risk in men and women","volume":"11","author":"Lin JH","year":"2013","unstructured":"Lin JH, Zhang SM, Rexrode KM, et al.. Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol. 2013, 11:419-424. 10.1016\/j.cgh.2012.11.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5177","article-title":"Obesity and colorectal cancer: role of adipokines in tumor initiation and progression","volume":"20","author":"Riondino S","year":"2014","unstructured":"Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, Guadagni F. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol. 2014, 20:5177-90. 10.3748\/wjg.v20.i18.5177","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102423","article-title":"Resistin enhances angiogenesis in osteosarcoma via the MAPK signaling pathway","volume":"11","author":"Tsai HC","year":"2019","unstructured":"Tsai HC, Cheng SP, Han CK, et al.. Resistin enhances angiogenesis in osteosarcoma via the MAPK signaling pathway. Aging (Albany NY). 2019, 11:9767-77. 10.18632\/aging.102423","journal-title":"Aging (Albany NY)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28450-1","article-title":"Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients","volume":"13","author":"Di Rosa M","year":"2023","unstructured":"Di Rosa M, Di Cataldo A, Broggi G, et al.. Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients. Sci Rep. 2023, 13:10.1038\/s41598-023-28450-1","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-019-00260-7","article-title":"Insulin resistance and colorectal cancer risk: the role of elevated plasma resistin levels","volume":"51","author":"Farahani H","year":"2020","unstructured":"Farahani H, Mahmoudi T, Asadi A, Nobakht H, Dabiri R, Hamta A. Insulin resistance and colorectal cancer risk: the role of elevated plasma resistin levels. J Gastrointest Cancer. 2020, 51:478-83. 10.1007\/s12029-019-00260-7","journal-title":"J Gastrointest Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5301\/jbm.5000079","article-title":"Resistin -420C>G promoter variant and colorectal cancer risk","volume":"29","author":"Mahmoudi T","year":"2014","unstructured":"Mahmoudi T, Karimi K, Arkani M, et al.. Resistin -420C>G promoter variant and colorectal cancer risk. Int J Biol Markers. 2014, 29:e233-8. 10.5301\/jbm.5000079","journal-title":"Int J Biol Markers"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee RR","year":"2004","unstructured":"Banerjee RR, Rangwala SM, Shapiro JS, et al.. Regulation of fasted blood glucose by resistin. Science. 2004, 303:1195-8. 10.1126\/science.1092341","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01306.x","article-title":"The current biology of resistin","volume":"255","author":"Steppan CM","year":"2004","unstructured":"Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004, 255:439-47. 10.1111\/j.1365-2796.2004.01306.x","journal-title":"J Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.7.1671","article-title":"Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting","volume":"53","author":"Rajala MW","year":"2004","unstructured":"Rajala MW, Qi Y, Patel HR, et al.. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004, 53:1671-9. 10.2337\/diabetes.53.7.1671","journal-title":"Diabetes"},{"key":"ref27","article-title":"Adiponectin and resistin - new hormones of white adipose tissue","volume":"9","author":"Be\u0142towski J","year":"2003","unstructured":"Be\u0142towski J. Adiponectin and resistin - new hormones of white adipose tissue. Med Sci Monit. 2003, 9:55-61.","journal-title":"Med Sci Monit"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: Implications for various human pathologies","volume":"133","author":"Filkov\u00e1 M","year":"2009","unstructured":"Filkov\u00e1 M, Haluz\u00edk M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009, 133:157-70. 10.1016\/j.clim.2009.07.013","journal-title":"Clin Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2012.01.004","article-title":"Resistin and cardiovascular disease","volume":"21","author":"Ding Q","year":"2011","unstructured":"Ding Q, White SP, Ling C, Zhou W. Resistin and cardiovascular disease. Trends Cardiovasc Med. 2011, 21:20-7. 10.1016\/j.tcm.2012.01.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2018-0011","article-title":"Resistin levels in non-alcoholic fatty liver disease pathogenesis","volume":"6","author":"Colica C","year":"2018","unstructured":"Colica C, Abenavoli L. Resistin levels in non-alcoholic fatty liver disease pathogenesis. J Transl Int Med. 2018, 6:52-3. 10.2478\/jtim-2018-0011","journal-title":"J Transl Int Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00431.2009","article-title":"Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells","volume":"299","author":"Chen C","year":"2010","unstructured":"Chen C, Jiang J, L\u00fc JM, Chai H, Wang X, Lin PH, Yao Q. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2010, 299:193-201. 10.1152\/ajpheart.00431.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1055\/a-0637-1975","article-title":"Correlation between resistin level and metabolic syndrome component: a review","volume":"50","author":"Mostafazadeh M","year":"2018","unstructured":"Mostafazadeh M, Haiaty S, Rastqar A, Keshvari M. Correlation between resistin level and metabolic syndrome component: a review. Horm Metab Res. 2018, 50:521-36. 10.1055\/a-0637-1975","journal-title":"Horm Metab Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.073","article-title":"Resistin, adiponectin, and risk of heart failure the Framingham offspring study","volume":"53","author":"Frankel DS","year":"2009","unstructured":"Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ, Meigs JB. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol. 2009, 53:754-62. 10.1016\/j.jacc.2008.07.073","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.229","article-title":"Linking resistin, inflammation, and cardiometabolic diseases","volume":"32","author":"Park HK","year":"2017","unstructured":"Park HK, Kwak MK, Kim HJ, Ahima RS. Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med. 2017, 32:239-47. 10.3904\/kjim.2016.229","journal-title":"Korean J Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2016.11.012","article-title":"Obesity and cancer. [Article in French]","volume":"104","author":"Sala\u00fcn H","year":"2017","unstructured":"Sala\u00fcn H, Thariat J, Vignot M, Merrouche Y, Vignot S. Obesity and cancer. [Article in French]. Bull Cancer. 2017, 104:30-41. 10.1016\/j.bulcan.2016.11.012","journal-title":"Bull Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition","volume":"11","author":"Thanikachalam K","year":"2019","unstructured":"Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. 2019, 11:10.3390\/nu11010164","journal-title":"Nutrients"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.orcp.2019.03.006","article-title":"Circulating adipokines and risk of obesity related cancers: a systematic review and meta-analysis","volume":"13","author":"Yoon YS","year":"2019","unstructured":"Yoon YS, Kwon AR, Lee YK, Oh SW. Circulating adipokines and risk of obesity related cancers: a systematic review and meta-analysis. Obes Res Clin Pract. 2019, 13:329-39. 10.1016\/j.orcp.2019.03.006","journal-title":"Obes Res Clin Pract"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225499","article-title":"Pre-diagnostic circulating resistin concentrations are not associated with colorectal cancer risk in the European prospective investigation into cancer and nutrition study","volume":"14","author":"Pham TT","year":"2022","unstructured":"Pham TT, Nimptsch K, Aleksandrova K, et al.. Pre-diagnostic circulating resistin concentrations are not associated with colorectal cancer risk in the European prospective investigation into cancer and nutrition study. Cancers (Basel). 2022, 14:10.3390\/cancers14225499","journal-title":"Cancers (Basel)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010045","article-title":"An inflammatory cascade leading to hyperresistinemia in humans","volume":"1","author":"Lehrke M","year":"2004","unstructured":"Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004, 1:10.1371\/journal.pmed.0010045","journal-title":"PLoS Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.06.202","article-title":"Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway","volume":"334","author":"Silswal N","year":"2005","unstructured":"Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005, 334:1092-101. 10.1016\/j.bbrc.2005.06.202","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1021\/bi034782v","article-title":"Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages","volume":"42","author":"Aruna B","year":"2003","unstructured":"Aruna B, Ghosh S, Singh AK, Mande SC, Srinivas V, Chauhan R, Ehtesham NZ. Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages. Biochemistry. 2003, 42:10554-9. 10.1021\/bi034782v","journal-title":"Biochemistry"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i8.754","article-title":"Effects of resistin-like molecule \u03b2 over-expression on gastric cancer cells in vitro","volume":"18","author":"Zheng LD","year":"2012","unstructured":"Zheng LD, Yang CL, Qi T, Qi M, Tong L, Tong QS. Effects of resistin-like molecule \u03b2 over-expression on gastric cancer cells in vitro. World J Gastroenterol. 2012, 18:754-66. 10.3748\/wjg.v18.i8.754","journal-title":"World J Gastroenterol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2012.01.012","article-title":"The effect of resistin on nuclear factor-kB and tumor necrosis factor-a expression in hepatic steatosis. [Article in Chinese]","volume":"20","author":"Qi MM","year":"2012","unstructured":"Qi MM, Guan XQ, Zhu LR, Wang LJ, Liu L, Yang YP. The effect of resistin on nuclear factor-kB and tumor necrosis factor-a expression in hepatic steatosis. [Article in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2012, 20:40-4. 10.3760\/cma.j.issn.1007-3418.2012.01.012","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2174\/092986712804143349","article-title":"Obesity-driven inflammation and colorectal cancer","volume":"19","author":"Vazzana N","year":"2012","unstructured":"Vazzana N, Riondino S, Toto V, Guadagni F, Roselli M, Davi G, Ferroni P. Obesity-driven inflammation and colorectal cancer. Curr Med Chem. 2012, 19:5837-53. 10.2174\/092986712804143349","journal-title":"Curr Med Chem"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00899.x","article-title":"Resistin competes with lipopolysaccharide for binding to toll-like receptor 4","volume":"14","author":"Tarkowski A","year":"2010","unstructured":"Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010, 14:1419-31. 10.1111\/j.1582-4934.2009.00899.x","journal-title":"J Cell Mol Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki A","year":"2004","unstructured":"Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004, 5:987-95. 10.1038\/ni1112","journal-title":"Nat Immunol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-006-0477-4","article-title":"Toll-like receptors (TLRs) and immune disorders","volume":"12","author":"Akashi-Takamura S","year":"2006","unstructured":"Akashi-Takamura S, Miyake K. Toll-like receptors (TLRs) and immune disorders. J Infect Chemother. 2006, 12:233-40. 10.1007\/s10156-006-0477-4","journal-title":"J Infect Chemother"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300738200","article-title":"Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein","volume":"278","author":"Walton KA","year":"2003","unstructured":"Walton KA, Hsieh X, Gharavi N, et al.. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem. 2003, 278:29661-6. 10.1074\/jbc.M300738200","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.09.015","article-title":"Resistin is secreted from macrophages in atheromas and promotes atherosclerosis","volume":"69","author":"Jung HS","year":"2006","unstructured":"Jung HS, Park KH, Cho YM, et al.. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res. 2006, 69:76-85. 10.1016\/j.cardiores.2005.09.015","journal-title":"Cardiovasc Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.10.023","article-title":"Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke","volume":"378","author":"Efstathiou SP","year":"2007","unstructured":"Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta. 2007, 378:78-85. 10.1016\/j.cca.2006.10.023","journal-title":"Clin Chim Acta"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00543.x","article-title":"Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases","volume":"101","author":"Yagmur E","year":"2006","unstructured":"Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol. 2006, 101:1244-52. 10.1111\/j.1572-0241.2006.00543.x","journal-title":"Am J Gastroenterol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2014-0037","article-title":"Adipose tissue, obesity and adipokines: role in cancer promotion","volume":"21","author":"Booth A","year":"2015","unstructured":"Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig. 2015, 21:57-74. 10.1515\/hmbci-2014-0037","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14236003","article-title":"Resistin promotes nasopharyngeal carcinoma metastasis through TLR4-mediated activation of p38 MAPK\/NF-\u03baB signaling pathway","volume":"14","author":"Zhang Z","year":"2022","unstructured":"Zhang Z, Du J, Xu Q, et al.. Resistin promotes nasopharyngeal carcinoma metastasis through TLR4-mediated activation of p38 MAPK\/NF-\u03baB signaling pathway. Cancers (Basel). 2022, 14:10.3390\/cancers14236003","journal-title":"Cancers (Basel)"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-112","article-title":"Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin","volume":"14","author":"Yang CC","year":"2014","unstructured":"Yang CC, Chang SF, Chao JK, Lai YL, Chang WE, Hsu WH, Kuo WH. Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin. BMC Cancer. 2014, 14:10.1186\/1471-2407-14-112","journal-title":"BMC Cancer"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi G","year":"2005","unstructured":"Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005, 115:911-9; quiz 920. 10.1016\/j.jaci.2005.02.023","journal-title":"J Allergy Clin Immunol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.12659\/msm.895598","article-title":"Resistin-like molecule-\u03b2 promotes invasion and migration of gastric carcinoma cells","volume":"22","author":"Jiang R","year":"2016","unstructured":"Jiang R, Zhao C, Wang X, Wang S, Sun X, Tian Y, Song W. Resistin-like molecule-\u03b2 promotes invasion and migration of gastric carcinoma cells. Med Sci Monit. 2016, 22:937-42. 10.12659\/msm.895598","journal-title":"Med Sci Monit"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte RS","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019, 176:1248-64. 10.1016\/j.cell.2019.01.021","journal-title":"Cell"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i39.4428","article-title":"Novel targeting approaches and signaling pathways of colorectal cancer: an insight","volume":"24","author":"Tiwari A","year":"2018","unstructured":"Tiwari A, Saraf S, Verma A, Panda PK, Jain SK. Novel targeting approaches and signaling pathways of colorectal cancer: an insight. World J Gastroenterol. 2018, 24:4428-35. 10.3748\/wjg.v24.i39.4428","journal-title":"World J Gastroenterol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.435","article-title":"Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer","volume":"7","author":"Zhi X","year":"2016","unstructured":"Zhi X, Tao J, Zhang L, Tao R, Ma L, Qin J. Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer. Cell Death Dis. 2016, 7:10.1038\/cddis.2016.435","journal-title":"Cell Death Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S139639","article-title":"Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy","volume":"10","author":"Wu C","year":"2017","unstructured":"Wu C, Zhu X, Liu W, Ruan T, Tao K. Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy. Onco Targets Ther. 2017, 10:3249-59. 10.2147\/OTT.S139639","journal-title":"Onco Targets Ther"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4847","article-title":"Emerging trends in colorectal cancer: dysregulated signaling pathways (review)","volume":"47","author":"Ahmad R","year":"2021","unstructured":"Ahmad R, Singh JK, Wunnava A, Al-Obeed O, Abdulla M, Srivastava SK. Emerging trends in colorectal cancer: dysregulated signaling pathways (review). Int J Mol Med. 2021, 47:10.3892\/ijmm.2021.4847","journal-title":"Int J Mol Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.07.005","article-title":"Obesity and cancer: inflammation bridges the two","volume":"29","author":"Kolb R","year":"2016","unstructured":"Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016, 29:77-89. 10.1016\/j.coph.2016.07.005","journal-title":"Curr Opin Pharmacol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081808","article-title":"Crosstalk between DNA damage and Inflammation in the multiple steps of carcinogenesis","volume":"18","author":"Kawanishi S","year":"2017","unstructured":"Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M. Crosstalk between DNA damage and Inflammation in the multiple steps of carcinogenesis. Int J Mol Sci. 2017, 18:10.3390\/ijms18081808","journal-title":"Int J Mol Sci"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0068","article-title":"Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells","volume":"38","author":"Miethe C","year":"2019","unstructured":"Miethe C, Zamora M, Torres L, Raign KG, Groll CJ, Price RS. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells. Horm Mol Biol Clin Investig. 2019, 38:10.1515\/hmbci-2018-0068","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.13.99","article-title":"Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives","volume":"8","author":"Dalamaga M","year":"2014","unstructured":"Dalamaga M. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomark Med. 2014, 8:107-18. 10.2217\/bmm.13.99","journal-title":"Biomark Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay J","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al.. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019, 144:1941-53. 10.1002\/ijc.31937","journal-title":"Int J Cancer"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla P","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019, 14:89-103. 10.5114\/pg.2018.81072","journal-title":"Prz Gastroenterol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer","volume":"62","author":"Bardou M","year":"2013","unstructured":"Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013, 62:933-47. 10.1136\/gutjnl-2013-304701","journal-title":"Gut"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2014.05.015","article-title":"Association between chemotherapy and plasma adipokines in patients with colorectal cancer","volume":"66","author":"S\u0142omian G","year":"2014","unstructured":"S\u0142omian G, \u015awi\u0119tochowska E, Malinowska-Borowska J, Kasperczyk S, Rogalska A, Nowak P. Association between chemotherapy and plasma adipokines in patients with colorectal cancer. Pharmacol Rep. 2014, 66:902-7. 10.1016\/j.pharep.2014.05.015","journal-title":"Pharmacol Rep"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2011.00504.x","article-title":"Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma","volume":"12","author":"Xu XT","year":"2011","unstructured":"Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, Ran ZH, Xiao SD. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis. 2011, 12:234-44. 10.1111\/j.1751-2980.2011.00504.x","journal-title":"J Dig Dis"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7941","article-title":"Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis","volume":"20","author":"Joshi RK","year":"2014","unstructured":"Joshi RK, Kim WJ, Lee SA. Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol. 2014, 20:7941-9. 10.3748\/wjg.v20.i24.7941","journal-title":"World J Gastroenterol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.1.397","article-title":"Obesity related adipokines and colorectal cancer: a review and meta-analysis","volume":"15","author":"Joshi RK","year":"2014","unstructured":"Joshi RK, Lee SA. Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev. 2014, 15:397-405. 10.7314\/apjcp.2014.15.1.397","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref74","article-title":"Serum levels of adipokines resistin and leptin in patients with colon cancer","volume":"3","author":"S\u0103l\u0103geanu A","year":"2010","unstructured":"S\u0103l\u0103geanu A, Tucureanu C, Lerescu L, et al.. Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life. 2010, 3:416-20.","journal-title":"J Med Life"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01518.x","article-title":"Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer","volume":"101","author":"Nakajima TE","year":"2010","unstructured":"Nakajima TE, Yamada Y, Hamano T, et al.. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci. 2010, 101:1286-91. 10.1111\/j.1349-7006.2010.01518.x","journal-title":"Cancer Sci"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-008-0605-y","article-title":"Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients","volume":"24","author":"Kumor A","year":"2009","unstructured":"Kumor A, Daniel P, Pietruczuk M, Ma\u0142ecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis. 2009, 24:275-81. 10.1007\/s00384-008-0605-y","journal-title":"Int J Colorectal Dis"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-009-0828-6","article-title":"Association between adiponectin, resistin, insulin resistance, and colorectal tumors","volume":"25","author":"Gonullu G","year":"2010","unstructured":"Gonullu G, Kahraman H, Bedir A, Bektas A, Y\u00fccel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis. 2010, 25:205-12. 10.1007\/s00384-009-0828-6","journal-title":"Int J Colorectal Dis"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8753175","article-title":"High expression of both resistin and fascin-1 predicts a poor prognosis in patients with colorectal cancer","volume":"2020","author":"Wang CQ","year":"2020","unstructured":"Wang CQ, Wang Y, Huang BF, et al.. High expression of both resistin and fascin-1 predicts a poor prognosis in patients with colorectal cancer. Biomed Res Int. 2020, 2020:10.1155\/2020\/8753175","journal-title":"Biomed Res Int"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i10.1252","article-title":"Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer","volume":"16","author":"Otake S","year":"2010","unstructured":"Otake S, Takeda H, Fujishima S, et al.. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol. 2010, 16:1252-7. 10.3748\/wjg.v16.i10.1252","journal-title":"World J Gastroenterol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2771","article-title":"Adipokines linking obesity with colorectal cancer risk in postmenopausal women","volume":"72","author":"Ho GY","year":"2012","unstructured":"Ho GY, Wang T, Gunter MJ, et al.. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res. 2012, 72:3029-37. 10.1158\/0008-5472.CAN-11-2771","journal-title":"Cancer Res"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-545","article-title":"Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls","volume":"12","author":"Hillenbrand A","year":"2012","unstructured":"Hillenbrand A, Fassler J, Huber N, et al.. Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer. 2012, 12:10.1186\/1471-2407-12-545","journal-title":"BMC Cancer"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0540-7","article-title":"Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes","volume":"20","author":"Deng L","year":"2020","unstructured":"Deng L, Zhao X, Chen M, Ji H, Zhang Q, Chen R, Wang Y. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes. BMC Endocr Disord. 2020, 20:10.1186\/s12902-020-0540-7","journal-title":"BMC Endocr Disord"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-019-00178-x","article-title":"Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine","volume":"10","author":"Mihajlovic M","year":"2019","unstructured":"Mihajlovic M, Ninic A, Sopic M, et al.. Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine. EPMA J. 2019, 10:307-16. 10.1007\/s13167-019-00178-x","journal-title":"EPMA J"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2010.00635.x","article-title":"Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels","volume":"75","author":"Lau CH","year":"2011","unstructured":"Lau CH, Muniandy S. Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann Hum Genet. 2011, 75:370-82. 10.1111\/j.1469-1809.2010.00635.x","journal-title":"Ann Hum Genet"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093466","article-title":"Disulfide-dependent multimeric assembly of resistin family hormones","volume":"304","author":"Patel SD","year":"2004","unstructured":"Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L. Disulfide-dependent multimeric assembly of resistin family hormones. Science. 2004, 304:1154-8. 10.1126\/science.1093466","journal-title":"Science"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-1656(03)00099-3","article-title":"Production and characterization of bioactive recombinant resistin in Escherichia coli","volume":"103","author":"Juan CC","year":"2003","unstructured":"Juan CC, Kan LS, Huang CC, Chen SS, Ho LT, Au LC. Production and characterization of bioactive recombinant resistin in Escherichia coli. J Biotechnol. 2003, 103:113-7. 10.1016\/s0168-1656(03)00099-3","journal-title":"J Biotechnol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1319-x","article-title":"Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans","volume":"47","author":"Cho YM","year":"2004","unstructured":"Cho YM, Youn BS, Chung SS, et al.. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia. 2004, 47:559-65. 10.1007\/s00125-003-1319-x","journal-title":"Diabetologia"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2014.334","article-title":"Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients","volume":"34","author":"Alharithy RN","year":"2014","unstructured":"Alharithy RN. Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients. Ann Saudi Med. 2014, 34:334-9. 10.5144\/0256-4947.2014.334","journal-title":"Ann Saudi Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.0188","article-title":"Possible relationship between the resistin gene C-420G polymorphism and colorectal cancer in a Turkish population","volume":"26","author":"D\u00fczk\u00f6yl\u00fc Y","year":"2015","unstructured":"D\u00fczk\u00f6yl\u00fc Y, Ar\u0131kan S, Turan S, et al.. Possible relationship between the resistin gene C-420G polymorphism and colorectal cancer in a Turkish population. Turk J Gastroenterol. 2015, 26:392-6. 10.5152\/tjg.2015.0188","journal-title":"Turk J Gastroenterol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0039","article-title":"Genetic variation in adipokine genes and risk of colorectal cancer","volume":"160","author":"Pechlivanis S","year":"2009","unstructured":"Pechlivanis S, Bermejo JL, Pardini B, et al.. Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol. 2009, 160:933-40. 10.1530\/EJE-09-0039","journal-title":"Eur J Endocrinol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1080\/07357900802087267","article-title":"Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype","volume":"26","author":"W\u00e5gsater D","year":"2008","unstructured":"W\u00e5gsater D, Mumtaz M, Lofgren S, Hugander A, Dimberg J. Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype. Cancer Invest. 2008, 26:1008-14. 10.1080\/07357900802087267","journal-title":"Cancer Invest"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.10.2709","article-title":"Association between rs1862513 and rs3745367 genetic polymorphisms of resistin and risk of cancer: a meta-analysis","volume":"19","author":"Hashemi M","year":"2018","unstructured":"Hashemi M, Bahari G, Tabasi F, Moazeni-Roodi A, Ghavami S. Association between rs1862513 and rs3745367 genetic polymorphisms of resistin and risk of cancer: a meta-analysis. Asian Pac J Cancer Prev. 2018, 19:2709-16. 10.22034\/APJCP.2018.19.10.2709","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref93","article-title":"Resistin in human colon cancer. Increased expression independently of resistin promoter C-180G genotype","volume":"31","author":"Al-Harithy RN","year":"2010","unstructured":"Al-Harithy RN, Al-Ghafari AB. Resistin in human colon cancer. Increased expression independently of resistin promoter C-180G genotype. Saudi Med J. 2010, 31:495-500.","journal-title":"Saudi Med J"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.3813","article-title":"Chemotherapy and plasma adipokines level in patients with colorectal cancer","volume":"71","author":"S\u0142omian G","year":"2017","unstructured":"S\u0142omian G, \u015awi\u0119tochowska E, Nowak G, Pawlas K, \u017belazko A, Nowak P. Chemotherapy and plasma adipokines level in patients with colorectal cancer. Postepy Hig Med Dosw (Online). 2017, 71:281-90. 10.5604\/01.3001.0010.3813","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070798","article-title":"Inhibition of NLRP3 by fermented quercetin decreases resistin-induced chemoresistance to 5-fluorouracil in human colorectal cancer cells","volume":"15","author":"Lee KC","year":"2022","unstructured":"Lee KC, Wu KL, Yen CK, Chang SF, Chen CN, Lu YC. Inhibition of NLRP3 by fermented quercetin decreases resistin-induced chemoresistance to 5-fluorouracil in human colorectal cancer cells. Pharmaceuticals (Basel). 2022, 15:10.3390\/ph15070798","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0355-2","article-title":"Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance","volume":"54","author":"Zheng LD","year":"2009","unstructured":"Zheng LD, Tong QS, Weng MX, et al.. Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance. Dig Dis Sci. 2009, 54:274-81. 10.1007\/s10620-008-0355-2","journal-title":"Dig Dis Sci"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.05.014","article-title":"Here, there and everywhere: resistin-like molecules in infection, inflammation, and metabolic disorders","volume":"110","author":"Pine GM","year":"2018","unstructured":"Pine GM, Batugedara HM, Nair MG. Here, there and everywhere: resistin-like molecules in infection, inflammation, and metabolic disorders. Cytokine. 2018, 110:442-51. 10.1016\/j.cyto.2018.05.014","journal-title":"Cytokine"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174019","article-title":"Roles and mechanisms of adipokines in drug resistance of tumor cells","volume":"899","author":"Li Y","year":"2021","unstructured":"Li Y, Yu C, Deng W. Roles and mechanisms of adipokines in drug resistance of tumor cells. Eur J Pharmacol. 2021, 899:10.1016\/j.ejphar.2021.174019","journal-title":"Eur J Pharmacol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11034","article-title":"Circulating resistin levels and obesity-related cancer risk: a meta-analysis","volume":"7","author":"Gong WJ","year":"2016","unstructured":"Gong WJ, Zheng W, Xiao L, et al.. Circulating resistin levels and obesity-related cancer risk: a meta-analysis. Oncotarget. 2016, 7:57694-704. 10.18632\/oncotarget.11034","journal-title":"Oncotarget"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12270","article-title":"Obesity and cancer: an angiogenic and inflammatory link","volume":"23","author":"Fukumura D","year":"2016","unstructured":"Fukumura D, Incio J, Shankaraiah RC, Jain RK. Obesity and cancer: an angiogenic and inflammatory link. Microcirculation. 2016, 23:191-206. 10.1111\/micc.12270","journal-title":"Microcirculation"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2019.01.004","article-title":"Resistin: a reappraisal","volume":"178","author":"Acquarone E","year":"2019","unstructured":"Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P. Resistin: a reappraisal. Mech Ageing Dev. 2019, 178:46-63. 10.1016\/j.mad.2019.01.004","journal-title":"Mech Ageing Dev"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.3626","article-title":"The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas","volume":"26","author":"Demir N","year":"2015","unstructured":"Demir N, Ah\u0131shal\u0131 E, Dolap\u00e7\u0131o\u011flu C, et al.. The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas. Turk J Gastroenterol. 2015, 26:20-4. 10.5152\/tjg.2015.3626","journal-title":"Turk J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266404-an-updated-review-of-resistin-and-colorectal-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T07:38:01Z","timestamp":1721979481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266404-an-updated-review-of-resistin-and-colorectal-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":102,"URL":"https:\/\/doi.org\/10.7759\/cureus.65403","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}